Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual misoprostol plus pericervical tourniquet for reducing blood loss during abdominal myomectomy
PACTR202507757694585Not yet recruiting
- Sponsor
- Self
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of misoprostol in Fibromyoma (LM) (2 arms), sponsored by Self. Primary endpoint: Mean intraoperative blood loss. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
misoprostol
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on PACTR202507757694585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507757694585.